Commerzbank Aktiengesellschaft’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Commerzbank Aktiengesellschaft's VRTX Position: Q2 2026 in Review
Commerzbank Aktiengesellschaft reduced its Vertex Pharmaceuticals (VRTX) stake by 5.8% in Q2 2026, selling an estimated $188K and leaving 6,857 shares worth $3.41M. The position accounts for 0.07% of the portfolio, ranked #113.
Commerzbank Aktiengesellschaft first reported a position in VRTX in Q2 2013 and has held it in 39 quarters since. The position peaked at $52.5M in Q3 2018. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Commerzbank Aktiengesellschaft held 6,857 shares of Vertex Pharmaceuticals worth $3.41M as of Q2 2026.
- Commerzbank Aktiengesellschaft sold 424 Vertex Pharmaceuticals shares in Q2 2026, an estimated $188K.
- Vertex Pharmaceuticals made up 0.07% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #113 holding.
- Commerzbank Aktiengesellschaft first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 39 quarters since.
- Commerzbank Aktiengesellschaft's Vertex Pharmaceuticals position peaked at $52.5M in Q3 2018.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.